| Dr Steven Boyd Ogden, MD | |
|
6301 Harris Pkwy Ste 300, Fort Worth, TX 76132-4245 | |
| (817) 877-3432 | |
| (817) 346-4394 |
| Full Name | Dr Steven Boyd Ogden |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 22 Years |
| Location | 6301 Harris Pkwy Ste 300, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114123080 | NPI | - | NPPES |
| 203161902 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | M6809 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cardiovascular Home Care Inc | Fort worth, TX | Home health agency |
| Restoring Function Hhc Llc | Fort worth, TX | Home health agency |
| Health Masters Homecare Inc | Fort worth, TX | Home health agency |
| Texas Health Harris Methodist Hospital Southwest F | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The West Texas Rehabilitation Center | 2860301215 | 361 |
| Texas Health Physicians Group | 4385535954 | 1182 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Labcyte, whose Echo liquid handling platforms move liquids with sound, today announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown. Labcyte's acoustic droplet ejection technology offers touchless transfer of a wide variety of fluids, with major benefits in life science applications including drug discovery, genomics, proteomics and diagnostics.
The use of bariatric surgery among older, severely obese patients was not associated with a decreased risk of death, according to a study in the June 15 issue of JAMA. This study is being released early online to coincide with its presentation at the AcademyHealth Annual Research Meeting.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 7 days ago
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Labcyte, whose Echo liquid handling platforms move liquids with sound, today announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown. Labcyte's acoustic droplet ejection technology offers touchless transfer of a wide variety of fluids, with major benefits in life science applications including drug discovery, genomics, proteomics and diagnostics.
The use of bariatric surgery among older, severely obese patients was not associated with a decreased risk of death, according to a study in the June 15 issue of JAMA. This study is being released early online to coincide with its presentation at the AcademyHealth Annual Research Meeting.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Boyd Ogden, MD 6301 Harris Pkwy Ste 300, Fort Worth, TX 76132-4245 Ph: (817) 877-3432 | Dr Steven Boyd Ogden, MD 6301 Harris Pkwy Ste 300, Fort Worth, TX 76132-4245 Ph: (817) 877-3432 |
News Archive
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
Labcyte, whose Echo liquid handling platforms move liquids with sound, today announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown. Labcyte's acoustic droplet ejection technology offers touchless transfer of a wide variety of fluids, with major benefits in life science applications including drug discovery, genomics, proteomics and diagnostics.
The use of bariatric surgery among older, severely obese patients was not associated with a decreased risk of death, according to a study in the June 15 issue of JAMA. This study is being released early online to coincide with its presentation at the AcademyHealth Annual Research Meeting.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 7 days ago
Dr. Mark P Kuper, D.O. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6251 Oakmont Blvd, Fort Worth, TX 76132 Phone: 817-735-9397 Fax: 817-735-8340 | |
Dr. Brian Matthew Danshaw, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 Harris Pkwy Ste 310, Fort Worth, TX 76132 Phone: 817-916-4685 Fax: 817-769-3718 | |
Harry Anderson Dollahite, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1401 8th Ave, Fort Worth, TX 76104 Phone: 817-922-9299 Fax: 817-923-3968 | |
Dr. Andrew Albert Indresano, M.D Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3160 N Tarrant Pkwy Ste 404, Fort Worth, TX 76177 Phone: 817-205-2939 Fax: 817-887-3015 | |
Dr. Bryan Anthony Reyes, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 W Terrell Ave, Fort Worth, TX 76104 Phone: 817-877-3277 Fax: 817-877-3280 | |
Stephanie Goldstein, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1500 Cooper St, Fort Worth, TX 76104 Phone: 682-885-4405 Fax: 682-885-4407 | |
Joe M Todd, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1106 Alston Ave Ste 201, Fort Worth, TX 76104 Phone: 817-921-3461 Fax: 817-921-5602 |